Organigram Global Inc (OGI) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Organigram Global Inc   (NASDAQ: OGI)


Organigram Global Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Organigram Global Inc's ROI in the third quarter of 2026?
Organigram Global Inc achieved a return on average invested assets (ROI) of 13.99 % in its third quarter of 2026, this is above OGI's average return on investment of -13.85%.
Organigram Global Inc invested over the 12 months ending in its third quarter of 2026 $405 million

ROI has improved compared to -7.03% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 227 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from to 2995.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter
Y / Y Investment Change TTM 33.6 % 19.69 % 22.93 % 24.05 % 25.44 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 577 374 334 334 334
Return On Investment (TTM) 13.99 % -7.03 % 1.82 % -3.07 % -4.54 %
OGI's Overall Ranking # 2995 # # # # 3358
Seq. Investment Change TTM 17.68 % 2.96 % 4.9 % 5.11 % 5.43 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 57 -24 6 -10 -14

OGI Company Profile >> Back to OGI Roi Comparisons >> See Annual OGI Return On Investment



Return On Investment OGI's Ranking
Within: No.
Industry # 78
Sector # 228
Overall # 2995

Return On Investment Statistics
High Average Low
-2.82 %
-13.85 %
-32.49 %
(Aug 31 2022)   (Aug 31 2020)







Financial Statements
Organigram Global Inc's III. Quarter Investments $ 577 Millions OGI's Balance sheet
Organigram Global Inc's III. Quarter Income $ 76 Millions Quarterly OGI's Income Statement
OGI's Income by Division See OGI's Income by Division


OGI Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Aug 31 2022)
2022		 (Aug 31 2021)
2021
Total Investments in Millions 334 272 211 399 418
Y / Y Investment Growth 22.73 % 28.72 % -46.96 % -4.61 % 34.14 %
Net Income in Millions -19 -33 -11 -11 -103
Y / Y Net Income Growth - - - - -
Annual Return On Investment -5.68 % -12.27 % -5.17 % -2.82 % -24.68 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OGI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OGI's Competitors
Subscribers only: Roi for Organigram Global Inc's Suppliers
Subscribers only: Return On Investment for OGI's Customers

Other Ratios
OGI's Roa OGI's Inventory Turnover Ratio OGI's Growth Rates OGI's Dividend Statistics
OGI's Profitability Ratios OGI's Asset Turnover Ratio OGI's Dividend Growth
OGI's Roe OGI's Valuation Ratios OGI's Financial Strength Ratios OGI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %

Date modified: 2026-10-15T05:23:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.